SNY Jan 2025 47.000 call
| Previous close | 3.5000 |
| Open | 3.5000 |
| Bid | 4.3000 |
| Ask | 6.1000 |
| Strike | 47.00 |
| Expiry date | 2025-01-17 |
| Day's range | 3.5000 - 3.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 167 |
BloombergBofA, BNP Poised to Win Lead Roles on $20 Billion Sanofi Spinoff
(Bloomberg) -- Bank of America Corp. and BNP Paribas SA are on the verge of winning lead roles arranging Sanofi’s separation of its consumer-health business, according to people familiar with the matter, in one of the year’s most sought-after banking assignments. Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackAt $2 Million Per Minute, Treasuries Mint Cash Like Never BeforeJudge Threatens Trump With Jail Over Gag Order ViolationsTreasury Rally Risks Running
Insider MonkeyRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
- Thomson Reuters StreetEvents
Q1 2024 Kymera Therapeutics Inc Earnings Call
Q1 2024 Kymera Therapeutics Inc Earnings Call
